Literature DB >> 20031330

Emerging trends in the seroprevalence of canine leishmaniasis in the Madrid region (central Spain).

R Gálvez1, G Miró, M A Descalzo, J Nieto, D Dado, O Martín, E Cubero, R Molina.   

Abstract

This report describes a cross-sectional serological survey of the epidemiology of canine leishmaniasis (CanL) performed in 2006 and 2007 in the Madrid region (central Spain) where the disease is endemic. The work presented here is one of the several studies conducted in different Spanish regions under the Integrated Project of the European Commission entitled Emerging Diseases in a changing European eNvironment (EDEN). The aim of this project is to identify and catalogue European ecosystems and environmental conditions that determine the spatial and temporal distributions and dynamics of several pathogenic agents including Leishmania infantum (EDEN-LEI). The study area (Madrid Autonomous Region) was selected on the grounds of its wide altitude range. This area was surveyed from NE to SW across its mountain range (Sistema Central) and plateau area. One thousand and seventy-six dogs from 32 villages were examined for clinical signs of CanL, and serum samples were obtained to determine several haematological and biochemical variables. Leishmaniasis-specific antibodies were identified using an indirect immunofluorescence antibody test (IFAT). 87 of the 1076 dogs were seropositive for the protozoan (IFAT: cut-off>or=1/80) indicating a seroprevalence of 8.1% (0-16.1% depending on the village). On the basis of a physical examination and the biochemical/haematological status of each dog, 32 of the 87 infected dogs were described as clinically healthy (37%). Seroprevalence showed a peak in young dogs (1-2 years) and a second larger peak among the older dogs (7-8 years). Factors correlated with a higher infection risk were age (OR=1.15 [95% CI: 1.07-1.22]), weight (OR=1.10 [95% CI: 1.04-1.16]), and living outdoors as opposed to in a home (OR=3.38 [95% CI: 1.42-8.05]). According to data from studies performed in 1992 in the same area, the seroprevalence of CanL has increased 1.54-fold [95% CI: 1.04-2.29]. Given that this increasing trend cannot be attributed to differences in the sociodemographic characteristics of the dog populations, it is proposed that environmental changes could have had an impact on vector and reservoir densities and their geographical distributions. Further studies designed to explain this trend should attempt to correlate sand fly densities and CanL seroprevalences with climate, land use and human changes. (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20031330     DOI: 10.1016/j.vetpar.2009.11.025

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  30 in total

1.  Diagnostic value of conjunctival swab sampling associated with nested PCR for different categories of dogs naturally exposed to Leishmania infantum infection.

Authors:  Trentina Di Muccio; Fabrizia Veronesi; Maria Teresa Antognoni; Andrea Onofri; Daniela Piergili Fioretti; Marina Gramiccia
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

Review 2.  Transmission and epidemiology of zoonotic protozoal diseases of companion animals.

Authors:  Kevin J Esch; Christine A Petersen
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.

Authors:  Guadalupe Miró; Rosa Gálvez; Cristeta Fraile; Miguel A Descalzo; Ricardo Molina
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

4.  Epidemiological implications of the use of various methods for the diagnosis of canine leishmaniasis in dogs with different characteristics and in differing prevalence scenarios.

Authors:  Manuel Morales-Yuste; Francisco Morillas-Márquez; Victoriano Díaz-Sáez; Sergio Barón-López; Carmen Acedo-Sánchez; Joaquina Martín-Sánchez
Journal:  Parasitol Res       Date:  2012-01-10       Impact factor: 2.289

5.  Leishmania infantum in wild rodents: reservoirs or just irrelevant incidental hosts?

Authors:  H M Navea-Pérez; V Díaz-Sáez; V Corpas-López; G Merino-Espinosa; F Morillas-Márquez; J Martín-Sánchez
Journal:  Parasitol Res       Date:  2015-03-24       Impact factor: 2.289

6.  A surveillance program on canine leishmaniasis in the public kennels of Emilia-Romagna Region, Northern Italy.

Authors:  Annalisa Santi; Maria Renzi; Raffaella Baldelli; Mattia Calzolari; Antonino Caminiti; Silvia Dell'Anna; Giorgio Galletti; Annalisa Lombardini; Giulia Paternoster; Marco Tamba
Journal:  Vector Borne Zoonotic Dis       Date:  2014-02-27       Impact factor: 2.133

7.  Canine leishmaniosis and its relationship to human visceral leishmaniasis in Eastern Uzbekistan.

Authors:  Dmitriy A Kovalenko; Shavkat A Razakov; Evgeny N Ponirovsky; Alon Warburg; Rokhat M Nasyrova; Valentina I Ponomareva; Aziza A Fatullaeva; Abdelmajeed Nasereddin; Eyal Klement; Mohammad Z Alam; Lionel F Schnur; Charles L Jaffe; Gabriele Schönian; Gad Baneth
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

8.  Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods.

Authors:  Wendel Coura-Vital; Marcos José Marques; Vanja Maria Veloso; Bruno Mendes Roatt; Rodrigo Dian de Oliveira Aguiar-Soares; Levi Eduardo Soares Reis; Samuel Leôncio Braga; Maria Helena Franco Morais; Alexandre Barbosa Reis; Mariângela Carneiro
Journal:  PLoS Negl Trop Dis       Date:  2011-08-16

9.  Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study.

Authors:  Guadalupe Miró; Ana Montoya; Xavier Roura; Rosa Gálvez; Angel Sainz
Journal:  Parasit Vectors       Date:  2013-04-22       Impact factor: 3.876

10.  Seroepidemiology of canine leishmaniosis in Évora (southern Portugal): 20-year trends.

Authors:  Henk D F H Schallig; Luís Cardoso; Saul J Semião-Santos
Journal:  Parasit Vectors       Date:  2013-04-15       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.